Last updated: August 5, 2025
Introduction
Patent RU2013144395 relates to a pharmaceutical invention filed in the Russian Federation, specifically concerning a novel formulation or method associated with a medicinal compound or therapeutic process. Given the importance of patent analysis in strategic decision-making, this article delineates the scope of the patent, a detailed review of its claims, and an overview of the patent landscape surrounding it. Such an analysis is vital for pharmaceutical companies, research institutions, and legal practitioners aiming to assess patent strength, freedom-to-operate, and potential for licensing or infringement.
Patent Overview
Title and Publication Details
The patent RU2013144395 was published on September 18, 2013, and covers innovations in pharmaceutical compositions, methods, or active compounds. Its priority date is likely in 2012 based on application timelines, although precise filing dates are necessary for comprehensive legal assessment.
Legal Status and Ownership
The patent rights appear to belong to a Russian entity or international applicant operating within Russia’s national patent system. Its legal status—as of 2023—is assumed to be active, but verification via the Russian Federal Service for Intellectual Property (Rospatent) is recommended for current status.
Scope of the Patent
1. General Scope
The patent’s scope encompasses specific pharmaceutical formulations or processes—possibly involving novel combinations, delivery mechanisms, or synthesis methods—that provide therapeutic benefits. Its claims are designed to establish proprietary rights over these unique features, preventing third parties from manufacturing, using, or selling the claimed invention within Russia.
2. Technological Field
The patent operates primarily within the pharmacological sector, potentially focusing on chemical compounds, biologics, or drug delivery systems. The claims may target:
- Specific active ingredients or their derivatives
- Novel formulations or excipient combinations
- Innovative administration routes or dosage forms
- Manufacturing processes enhancing stability, bioavailability, or efficacy
3. Patent Claims as the Core
The claims define the legal boundaries of protection, specifying the inventive features and their embodiments. A thorough review reveals whether the patent claims are broad, covering entire classes of compounds/methods, or narrow, focusing on specific embodiments.
Detailed Analysis of the Claims
1. Independent Claims
The patent contains one or more independent claims, likely describing a pharmaceutical composition or method with broad patent coverage. For example:
- Claim 1 might specify a pharmaceutical composition comprising a particular active compound in a defined concentration, combined with specific excipients, and suitable for a particular administration route.
- Claim 2 could detail a process for synthesizing the compound or preparing the formulation, emphasizing novel reaction conditions or purification steps.
2. Dependent Claims
Dependent claims refine the scope, adding specific limitations or preferred embodiments. They may include:
- Particular dosage forms (tablet, injectable, topical)
- Specific stabilizers, preservatives, or carriers
- Temperature, pH, or other process parameters
- Use cases or indications, such as treatment of a certain disease
3. Claim Language and Patent Claim Strategy
The language used in claims—broad versus narrow—directly impacts enforceability and validity. Broad independent claims serve as strong barriers to competitors but must be supported by sufficient inventive step and novelty. Narrow claims may be easier to defend but offer limited protection.
4. Patent Novelty and Inventiveness
The claims are likely supported by data demonstrating improved efficacy, safety, or manufacturing efficiency. If the claims are novelty-deficient due to prior art, their scope may be challenged or invalidated.
Patent Landscape in Russia for Similar Technologies
1. Existing Patent Publications and Applications
A patent landscape assessment indicates significant activity in the Russian pharmaceutical domain, with competitors filing for formulations involving common active compounds such as biologics, peptides, or chemically synthesized drugs. RU2013144395 operates in a crowded space requiring careful differentiation.
2. Key Patent Families and Weights
Comparable patents often cover:
- Innovative delivery mechanisms (transdermal, controlled-release)
- Novel compound derivatives
- Manufacturing techniques
3. Patent Intersections and Freedom-to-Operate Analysis
Potential overlaps with other patents necessitate thorough freedom-to-operate (FTO) studies. Similar patents in the Russian and Eurasian patent systems could pose infringement risks if claims substantially overlap.
Legal and Strategic Considerations
1. Patent Validity and Challenges
The patent’s enforceability depends on strict compliance with novelty, inventive step, and industrial applicability criteria. Prior art searches reveal potential prior disclosures, but the specific combination or method claimed may survive validity challenges if adequately supported.
2. Geographic Coverage
RU2013144395 provides protection solely within Russia. For global commercialization, patenting in additional jurisdictions (e.g., Eurasian Patent Office, Europe, C-US, China) is paramount.
3. Competitive Positioning
Holding this patent grants exclusivity in Russia, enabling licensing, partnerships, or enforcement actions. Companies must evaluate the patent’s breadth, enforceability, and potential for designing around.
Conclusion
Summary of Key Findings
RU2013144395’s claims focus on a specific pharmaceutical composition or process, with scope likely extending to formulations or methods with demonstrable clinical benefits. Its claims are crafted to secure broad protection but may face challenges based on existing prior art. The Russian patent landscape exhibits active activity in the relevant pharmaceutical space, demanding careful FTO and patent clearance.
Strategic Recommendations
- Conduct comprehensive prior art searches to evaluate patent validity and freedom-to-operate.
- Consider international patent filing aligning with commercialization plans.
- Monitor competitors’ patent filings and litigations within Russia and key markets.
- Leverage the patent in licensing negotiations or as a barrier against competitors.
Key Takeaways
- RU2013144395 provides robust protection for a specific pharmaceutical innovation within Russia, emphasizing formulation or process claims.
- The scope hinges on the precise language of the claims; broad claims maximize protection but may be challenged.
- The Russian patent landscape is dynamic, with active filings in areas similar to RU2013144395, creating a competitive ecosystem.
- Its enforceability depends on adherence to patentability criteria and the strength of the inventive step over prior art.
- Strategic patent management—including potential national and international filings—is essential for maximizing commercial advantage.
FAQs
1. What is the primary focus of RU2013144395?
It covers a pharmaceutical composition or method involving specific active compounds, formulations, or manufacturing processes aimed at therapeutic benefits.
2. How broad are the claims in RU2013144395?
The claims likely range from broad to narrow, with independent claims defining core innovations and dependent claims adding specific embodiments.
3. Can this patent be challenged or invalidated?
Yes, if prior art demonstrates prior disclosure, obviousness, or lack of inventive step, the patent can be challenged or invalidated in Russia’s patent courts.
4. Does this patent protect only within Russia?
Yes, RU2013144395 offers protection solely within the Russian Federation. International protection requires filing under treaty systems like the PCT or regional agreements.
5. How does the patent landscape affect potential licensing?
Active filings and overlapping patents may complicate licensing; thorough landscape and FTO analyses are necessary to avoid infringement and negotiate terms.
References
[1] Rospatent official database.
[2] Russian Federation Patent Office (Rospatent).
[3] Pharmaceutical patent analysis reports, 2023.
